ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Assessment of immune status of laryngeal squamous cell carcinoma can predict prognosis and guide treatment

Wang, Xueying; Cao, Kui; Guo, Erliang; Mao, Xionghui; An, Changming; Guo, Lunhua; Zhang, Cong; Guo, Junnan; Yang, Xianguang; Sun, Ji; Yang, Weiwei; Li, Xiaomei*; Miao, Susheng*哈尔滨医科大学; 中国医学科学院
Cancer Immunology, Immunotherapy2022-5DOI: 10.1007/s00262-021-03071-7
10被引8阅读
引用收藏
分享

摘要

Background In the past few years, immunotherapy has changed the way we treat solid tumors. People pay more and more attention to the immune microenvironment of laryngeal squamous cell carcinoma (LSCC). In this study, our immunotherapy research took advantage of the clinical database and focused our in-depth analysis on the tumor microenvironment (TME). Methods This study evaluated the relationship between the clinical outcome and the local tissue and overall immune status in 412 patients with primary LSCC. We constructed and validated a risk model that could predict prognosis, assess immune status, identify high-risk patients, and develop personalized treatment plans through bioinformatics. In addition, through immunohistochemical analysis, we verified the differential expression of CTSL and KDM5D genes with the largest weight coefficients in the model in LSCC tissues and their influence on the prognosis and tumor-infiltrating lymphocytes (TILs). Results We found that interstitial tumor-infiltrating lymphocytes, tumor parenchymal-infiltrating lymphocyte volume, tumor infiltrates lymphocytes of frontier invasion, and the platelet-to-lymphocyte ratio (PLR) were independent factors affecting the prognosis of patients with LSCC. A novel risk model can guide clinicians to accurately predict prognosis, identify high-risk patients, and formulate personalized treatment plans. The differential expression of genes such as CTSL and KDM5D has a significant correlation with the TILs of LSCC and the prognosis of patients. Conclusion Local and systemic inflammatory markers in patients with laryngeal squamous cell carcinoma are reliable prognostic factors. The risk model and CTSL, KDM5D gene have important potential research value.

学科与关键词

关键词
Laryngeal squamous cell carcinoma (LSCC)Intratumoral infiltrating lymphocytes (iTILs)Infiltrating lymphocyte volume (TILv)Tumor infiltrates lymphocytes of frontier invasion (TILf)Immunotherapy
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Cancer Immunology, Immunotherapy
发表日期
2022-05
卷期
第 71 卷, 第 5 期
页码
1199-1220
DOI
10.1007/s00262-021-03071-7
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
Postdoctoral Scientific Research Developmental Fund of Heilongjiang Province [LBH-Q18088]

作者

  • W

    Wang, Xueying (第一作者)

    harbin med univ

  • C

    Cao, Kui

    harbin med univ

查看全部 13 位作者收起作者
  • G

    Guo, Erliang

    2 · harbin med univ

  • M

    Mao, Xionghui

    harbin med univ

  • A

    An, Changming

    chinese acad med sci

  • G

    Guo, Lunhua

    harbin med univ

  • Z

    Zhang, Cong

    harbin med univ

  • G

    Guo, Junnan

    harbin med univ

  • Y

    Yang, Xianguang

    harbin med univ

  • S

    Sun, Ji

    harbin med univ

  • Y

    Yang, Weiwei

    harbin med univ

  • L

    Li, Xiaomei (通讯)

    harbin med univ

  • M

    Miao, Susheng (通讯)

    harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417